Stockreport

AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024 [Yahoo! Finance]

AbCellera Biologics Inc. - Common Shares  (ABCL) 
PDF CD3-binding antibodies that consistently generate T-cell engagers with potent tumor-cell killing and low cytokine release across multiple tumor targets, including PSMA, [Read more]